Interestingly, Slc25a1-/- embryos also displayed an enrichment of tumor-associated transcriptional signatures involved in breast cancer, neuroblastoma, ovarian cancer, and others, as well as induction of the p53 tumor suppressor (Supplementary Fig. 4B). Here, SLC25A1 is linked to ovarian cancer.